powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1962722553
Sudha Yalamanchi
M.D.
Endocrinology
Elmhurst,
IL
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
75.9
Cost
74.6
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.42%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
2,054
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
26
Brand share
54.1%
Top prescribed drugs
Glipizide
264 claims
Levothyroxine Sodium
227 claims
Semaglutide
205 claims
Dulaglutide
187 claims
Metformin Hcl
108 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
667
Unique beneficiaries
—
Total services
7,283
Distinct HCPCS
7
Medicare payment
$184K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 262 Endocrinology providers in IL — top quintile (cohort median 1,061).